Renal Cell Carcinoma Highlights From ASCO GU 2024 Renal Cell Carcinoma Highlights From ASCO GU 2024
Key data in renal cell carcinoma from ASCO GU 2024 includes pembrolizumab in early higher-risk RCC, belzutifan in advanced disease, and developments in quality-of-life tools.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2024 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
Advancements in RCC Treatment and Cure Rates Advancements in RCC Treatment and Cure Rates
Dr Katy Beckermann expresses optimism for the future of the treatment of renal cell carcinoma through the safe combination of new therapeutic agents.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2024 Category: Consumer Health News Tags: None MDAngle Source Type: news
ADC optimal cutoff reduces MRI-prompted breast biopsies
Applying point-of-care apparent diffusion coefficient (ADC) cutoffs from diffusion-weighted imaging (DWI) could reduce MRI-prompted breast biopsies, a study published February 13 in Radiology found.
Researchers led by Inyoung Youn, MD, PhD, from the University of Washington in Seattle found that applying these cutoffs led to a nearly 16% decrease in breast biopsies. They also reported a tradeoff of lowered sensitivity for in situ and microinvasive disease manifesting as nonmass enhancements.
“Our study results support adoption of [ADC] cutoffs in the clinical setting, with the caveat that radiologists may need to be mo...
Source: AuntMinnie.com Headlines - February 15, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Breast Imaging Source Type: news
Unmet social needs tied to screening mammography use
Women's unmet social needs should be considered to better promote breast cancer screening utilization and early-stage cancer diagnosis, suggest findings published February 13 in JAMA Network Open.
Researchers led by Neha Goel, MD, from the University of Miami in Florida found that access to screening mammography did not translate to mammography use and that increasing unmet social needs were tied to lower rates of screening mammography. Also, women with high levels of unmet social needs were more likely to present with late-stage breast disease.
“This novel research is important as diagnosis at a later stage significan...
Source: AuntMinnie.com Headlines - February 14, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Do we recognize oral cancer? Primary professional delay in diagnosis of oral squamous cell carcinoma
ConclusionsOSCC patients seek care actively. Primary professional delay affects the care of every tenth OSCC patient.Clinical relevanceThe
role of health care professionals is essential for early OSCC
diagnosis, especially in urgent care. Clinicians ’ knowledge of the
typical symptoms and findings of OSCC should be improved. (Source: Dental Technology Blog)
Source: Dental Technology Blog - February 14, 2024 Category: Dentistry Source Type: news
Could CEM be suitable alternative for imaging lobular carcinoma?
Contrast-enhanced mammography (CEM) can locally stage lobular breast carcinomas and could serve as an alternative to breast MRI, according to research published February 12 in Clinical Radiology.
A team led by Elisabetta Giannotti, MD, from Hospital NHS Foundation Trust in Cambridge, U.K., found that CEM had superior sensitivity compared to standard mammography and that both CEM and MRI overestimate tumor size to a similar degree.
"Traditionally, breast MRI has been used in many centers for preoperative staging, but CEM appears to be a suitable alternative,” the Giannotti team wrote.
Invasive lobular carcinoma is the ...
Source: AuntMinnie.com Headlines - February 13, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Breast Imaging Source Type: news
Experimental Low-Cost Blood Test Can Detect Multiple Cancers, Researchers Say
Test uses a new ultrasensitive immunoassay to detect a known clinical laboratory diagnostic protein biomarker for many common cancers Researchers from Mass General Brigham, the Dana-Farber Cancer Institute, Harvard University’s Wyss Institute and other institutions around the world have reportedly developed a simple clinical laboratory blood test that can detect a common protein biomarker associated […]
The post Experimental Low-Cost Blood Test Can Detect Multiple Cancers, Researchers Say appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - February 12, 2024 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory Instruments & Laboratory Equipment Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing anatomic pathology blood plasma Brigham and Women’s Hospital cancer Cancer Discovery carcinomas clinical lab Source Type: news
Tools on the Horizon for Managing Posttransplant cSCC Risk Tools on the Horizon for Managing Posttransplant cSCC Risk
Organ transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients.MDedge News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - February 9, 2024 Category: Transplant Surgery Tags: Dermatology Source Type: news
Low-dose PEM shows promise in breast cancer detection
Low-dose positron emission mammography (PEM) can detect invasive breast cancer in a feasible manner, according to research published February 9 in Radiology: Imaging Cancer.
A team led by Vivianne Freitas, MD, from the University of Toronto found that PEM performed comparably to MRI in breast cancer detection and could serve as a supplemental imaging method for evaluating dense breasts.
"This groundbreaking imaging technique presents a compelling alternative, mirroring the clinical utility of traditional mammography and MRI but utilizing considerably lower doses of radiation when compared with previously molecular breast...
Source: AuntMinnie.com Headlines - February 9, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
University Hospitals Birmingham Claims Its New AI Model Detects Certain Skin Cancers with Nearly 100% Accuracy
But dermatologists and other cancer doctors still say AI is not ready to operate without oversight by clinical physicians Dermatopathologists and the anatomic pathology profession in general have a new example of how artificial intelligence’s (AI’s) ability to detect cancer with accuracy comparable to a trained pathologist has greatly improved. At the latest European Academy […]
The post University Hospitals Birmingham Claims Its New AI Model Detects Certain Skin Cancers with Nearly 100% Accuracy appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - February 7, 2024 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Digital Pathology Laboratory Instruments & Laboratory Equipment Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing AI anatomic pathology artificial intelligence basal cell carcinoma clinical laboratory clini Source Type: news
Machine Learning Helps Predict HCC Risk in MASLD Machine Learning Helps Predict HCC Risk in MASLD
A machine learning model can help estimate the risk for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 6, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
CEM image quality unaffected by iron particles from tracers
Low-dose iron oxide tracers impact the quality of breast MR images, but not that of contrast-enhanced mammography (CEM), a study published February 5 in Surgical Oncology found.
Researchers led by Elisabeth van Haaren from the Zuyderland Medical Centre in Sittard-Geleen, the Netherlands, found that even after a low-dose injection (1 ml) of superparamagnetic iron oxide (SPIO) tracer, iron remnants stay behind in the breast tissue and disturb all MR images. However, they also observed no such effect on CEM images.
“CEM could be valuable alternative if additional imaging is needed in the follow-up of breast cancer,” van...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Subspecialties MRI Ultrasound Breast Imaging Source Type: news
CEM image quality unaffected by iron particles from tracers
Low-dose iron oxide tracers impact the quality of breast MR images, but not that of contrast-enhanced mammography (CEM), a study published February 5 in Surgical Oncology found.
Researchers led by Elisabeth van Haaren from the Zuyderland Medical Centre in Sittard-Geleen, the Netherlands, found that even after a low-dose injection (1 ml) of superparamagnetic iron oxide (SPIO) tracer, iron remnants stay behind in the breast tissue and disturb all MR images. However, they also observed no such effect on CEM images.
“CEM could be valuable alternative if additional imaging is needed in the follow-up of breast cancer,” van...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Subspecialties MRI Ultrasound Breast Imaging Source Type: news
' Breakthrough': Adjuvant Pembro Ups Survival in Renal Cancer'Breakthrough': Adjuvant Pembro Ups Survival in Renal Cancer
KEYNOTE-564 is the first trial to demonstrate an overall survival benefit with adjuvant immunotherapy in patients with clear cell renal cell carcinoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Pembrolizumab Shows Survival Benefit for Patients With Renal Cancer
WEDNESDAY, Jan. 31, 2024 -- For patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months, according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2024 Category: Pharmaceuticals Source Type: news
